Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by AmorFatiforlifeon Dec 19, 2019 11:43pm

165 Views

Post# 30475352

TIGRIS

Hey everyone. Firstly Merry Christmas and Happy Holidays. All the best to you and your families for the new year. I was curious if anyone knows if, at this point, there can be patients selected from the 6 locations that have already been chosen, or do all 10 locations have to be selected before they can initiate the trial? I feel that 2020 is going to be a prosperous year for us all. Regards

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property